Harvard Bioscience (HBIO) Profit After Tax Growth (1y) (2011 - 2026)
Harvard Bioscience (HBIO) Profit After Tax Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 18.51% |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -21.43% |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 0.98% |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | -64.18% |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 16.84% |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 2.22% |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -157.64% |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 10.66% |
| 10 | Harvard Bioscience | 33.45 Mn | 26.94 Mn | 12.63 Mn | -27.52% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -27.52% |
| Mar 31, 2026 | 93.20% |
| Dec 31, 2025 | -15,916.67% |
| Sep 30, 2025 | 74.36% |
| Jun 30, 2025 | 22.04% |
| Mar 31, 2025 | -972.43% |
| Dec 31, 2024 | 100.99% |
| Sep 30, 2024 | -287.57% |
| Jun 30, 2024 | -198.67% |
| Mar 31, 2024 | -854.66% |
| Dec 31, 2023 | -9.12% |
| Sep 30, 2023 | 63.61% |
| Jun 30, 2023 | -140.25% |
| Mar 31, 2023 | 109.04% |
| Dec 31, 2022 | -273.36% |
| Sep 30, 2022 | -1,902.94% |
| Jun 30, 2022 | 693.90% |
| Mar 31, 2022 | -928.40% |
| Dec 31, 2021 | 256.26% |
| Sep 30, 2021 | 84.52% |